CRP and neoplasm: The significance of serum elevation of CRP as an indicator of tumour malignant potential and outcome of patients has been investigated in human gastrointestinal carcinomas [9, 10], renal cell carcinoma [11], ovarian carcinoma [12] and myeloma [13].